Literature DB >> 12368149

[Molecular genetics: pre- and post-analytic "best practices"].

D Duchassaing1, B Dingeon, J Chalas, M Coude, M P Coulhon, J M Launay.   

Abstract

Medical prescriptions for molecular genetic analyses are not yet very common in general practice, neverless they are becoming more and more frequent, and therefore it is more difficult to deal with them in part because of the recent french rules. Laboratory managers are supposed to be able to deal with such requests. This document, describing good laboratory practices, has been elaborated by members of the group "molecular genetics" from the "College National de Biochimie des Hôpitaux", providing details about: assessment of the prescriptions, including patient's consent, choice of the executing laboratory, specimen transmission, assessment and control of clinical and biological data, results transmission, confidentiality, archiving system. Such recommendations should facilitate exchanges with specialized laboratories, being specifically approved for practicing such analyses. The authors draw the attention of laboratory managers to the specificities of such requests.

Entities:  

Mesh:

Year:  2002        PMID: 12368149

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  1 in total

1.  Neonatal screening for cystic fibrosis: France rises to the challenge.

Authors:  J P Farriaux; M Vidailhet; M L Briard; V Belot; J L Dhondt
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.